1992
DOI: 10.1016/0006-8993(92)90713-j
|View full text |Cite
|
Sign up to set email alerts
|

Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3, 4-methylenedioxymethamphetamine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

12
209
1
1

Year Published

1996
1996
2013
2013

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 337 publications
(223 citation statements)
references
References 34 publications
12
209
1
1
Order By: Relevance
“…2). Extracellular concentrations of GLU in response to METH were similar in duration and magnitude to those reported previously (Abekawa et al, 1994;Nash and Yamamoto, 1992). The current study did not examine the mechanism of the METH-induced increases in striatal GLU, but previous studies showed a D1 receptor-dependent activation of the striatonigral GABAergic pathway (Mark et al, 2004), resulting in a disinhibition of corticostriatal GLUergic projections (Burrows and Meshul, 1999).…”
Section: Discussionsupporting
confidence: 83%
See 1 more Smart Citation
“…2). Extracellular concentrations of GLU in response to METH were similar in duration and magnitude to those reported previously (Abekawa et al, 1994;Nash and Yamamoto, 1992). The current study did not examine the mechanism of the METH-induced increases in striatal GLU, but previous studies showed a D1 receptor-dependent activation of the striatonigral GABAergic pathway (Mark et al, 2004), resulting in a disinhibition of corticostriatal GLUergic projections (Burrows and Meshul, 1999).…”
Section: Discussionsupporting
confidence: 83%
“…The neurotoxic effects are evidenced by long-term depletions in striatal dopamine (DA) and serotonin (5-HT) concentrations, and their uptake sites (Friedman et al, 1998;Ricaurte et al, 1982;Wagner et al, 1980), decreases in tryptophan and tyrosine hydroxylase activity (Bakhit et al, 1981), and cell loss (Deng et al, 2007;Sonsalla et al, 1996;Thiriet et al, 2005;Yu et al, 2004;Zhu et al, 2006). In addition to the hypotheses of oxidative stress and apoptosis as mechanisms of METH-induced neurotoxicity (for review, see Davidson et al, 2001;Kita et al, 2003;Quinton and Yamamoto, 2006), increases in the extracellular concentrations of glutamate (GLU) have been also suggested to play an important role (Abekawa et al, 1994;Nash and Yamamoto, 1992;Sonsalla et al, 1989;Stephans and Yamamoto, 1994). Recently, it has been demonstrated that spectrin proteolysis resulting from the activation of ionotropic GLU receptors, influx of Ca 2+ , and the subsequent activation of the calcium-dependent protease, calpain (Siman et al, 1989), is increased after METH administration (Staszewski and Yamamoto, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…In fact a variety of neurotransmitters are released under METH administration - namely, serotonin [66] glutamate [67-69] and acetylcholine [70, 71]. Among these, catecholamine neurons are considered as the main target since METH is a powerful DA and NE releaser [72, 73].…”
Section: Molecular Effects Of Methamphetamine (Meth) On Catecholaminementioning
confidence: 99%
“…It is likely that METH-induced glutamate release in limbic brain regions may reach the threshold to trigger convulsive seizures in the absence of endogenous NE. In fact, METH is a powerful glutamate releaser [67-69], while NE is considered to be a pivotal endogenous seizure suppressive mechanism [20, 140-143]. …”
Section: The Role Of Ne In Methamphetamine-induced Behavioural Changesmentioning
confidence: 99%
“…Whereas repeated cocaine administration produces robust drug-induced glutamate sensitization within the NAC [e.g., 31,35,47,57], repeated dosing with non-toxic regimens of amphetamine or methamphetamine elicits little effect upon the capacity of these drugs to alter glutamate levels within the corticoaccumbens pathway [61,272]. In contrast, repeated high dose amphetamine or methamphetamine regimens that induce dopamine neurotoxicity produce an increase in glutamate content within the PFC [273], a delayed increase in dorsal and ventral striatal glutamate levels [60,[274][275][276][277] and enhance potassium-stimulated, but not methamphetaminestimulated, glutamate release within the PFC [277]. Whether or not the more modest effects of amphetamine regimens upon corticoaccumbens glutamate relate to the duration of withdrawal remains to be determined.…”
Section: Homers and Methamphetaminementioning
confidence: 99%